21:45 IST
BSE
Board Meeting Date
Beryl Drugs Board Meeting Date
Beryl Drugs Ltd has scheduled a Board Meeting for September 2, 2026, to approve the Board report and matters related to its 33rd Annual General Meeting.
Beryl Drugs Ltd
- Share price
- ₹25.55
- Market cap
- ₹12.96 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.8×Sector 47.3×
- Promoter holding
- 27.82%+0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Outcome 4Board Meeting Date 4Annual General Meeting 4Promoter Buying 3Other Announcement 3Financial Results 3Debt & Borrowing 1Capacity Expansion 1Annual Report 1Adverse Business Impact 1
Time
4 announcements with these filters
15:04 IST
BSE
Board Meeting Date
Beryl Drugs Board Meeting Date
Beryl Drugs Ltd's Board of Directors will meet on August 11, 2026, to approve unaudited financial results for the quarter ended June 30, 2026.
18:54 IST
BSE
Board Meeting Date
Beryl Drugs Board Meeting Date
Beryl Drugs scheduled a board meeting for June 16, 2026. The board will consider shifting the company's registered office within the local limits of Indore.
21:06 IST
BSE
Board Meeting Date
Beryl Drugs Board Meeting Date
Beryl Drugs Ltd scheduled a board meeting on May 28, 2026, to approve audited financial results. The meeting will also consider related party transactions.